Prot# CVT 4129: An Open-Label, Sequential-Group, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous Tecadenoson Alone & in Combination with a Beta-Blocker in Adults with Rapid Atrial Fibrillation or Flutter

Project: Research project

Project Details

StatusFinished
Effective start/end date5/2/07 → 7/31/08

Funding

  • CV Therapeutics, Inc. (CVT 4129)